Release Date: 06/09/10 08:26 Summary: FDA Grants HeartWare Second Patient Allotment Under CAP Price Sensitive: Yes Download Document 89KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status